NPRLean L·
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Read at NPR →
US · 2 sources covering this
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Coverage spectrum
2 L · 0 C · 0 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/ec2f97025ad9e35b74e350ed4dec1d085841149e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Key FDA committee unanimously recommends its first vaccine since 2023"></iframe>
